FR2789M - New drug in particular for the treatment of hypercholesterolemia and the resulting disorders. - Google Patents

New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.

Info

Publication number
FR2789M
FR2789M FR932864A FR932864A FR2789M FR 2789 M FR2789 M FR 2789M FR 932864 A FR932864 A FR 932864A FR 932864 A FR932864 A FR 932864A FR 2789 M FR2789 M FR 2789M
Authority
FR
France
Prior art keywords
hypercholesterolemia
treatment
new drug
resulting disorders
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR932864A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR870686A external-priority patent/FR1338308A/en
Priority claimed from FR923333A external-priority patent/FR90803E/en
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR932864A priority Critical patent/FR2789M/en
Application granted granted Critical
Publication of FR2789M publication Critical patent/FR2789M/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
FR932864A 1961-08-11 1963-04-26 New drug in particular for the treatment of hypercholesterolemia and the resulting disorders. Expired FR2789M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR932864A FR2789M (en) 1961-08-11 1963-04-26 New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR870686A FR1338308A (en) 1961-08-11 1961-08-11 Aromatic steroids substituted in position 3 and method of preparation
FR923333A FR90803E (en) 1961-08-11 1963-01-31 Aromatic steroids substituted in position 3 and method of preparation
FR932864A FR2789M (en) 1961-08-11 1963-04-26 New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR941608A FR90804E (en) 1961-08-11 1963-07-16 Aromatic steroids substituted in position 3 and method of preparation

Publications (1)

Publication Number Publication Date
FR2789M true FR2789M (en) 1964-09-14

Family

ID=27445340

Family Applications (1)

Application Number Title Priority Date Filing Date
FR932864A Expired FR2789M (en) 1961-08-11 1963-04-26 New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.

Country Status (1)

Country Link
FR (1) FR2789M (en)

Similar Documents

Publication Publication Date Title
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR1994M (en) New drug in particular for the treatment of manifestations due to hyperlipemia or hypercholesterolemia.
FR3851M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3845M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1958M (en) New drug in particular for the treatment of andropause, senescence and disorders of protein anabolism and cell building.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR3532M (en) New drug, in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2789M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3031M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR1594M (en) New drug in particular for the treatment of hypercholesterolemia and disorders due to acute or chronic hyperlipemia.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
FR1485M (en) New drug in particular for the treatment of hyper cholesterolemia and the resulting disorders.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR1143M (en) Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia.
FR2974M (en) New drug in particular for the treatment of spasms of coronary origin and circulatory disorders.
FR1372M (en) New drug, in particular for the treatment of manifestations of hyperemotion, anxiety and disorders due to hyperexcitability.
FR1513M (en) New drug in particular for the treatment of manifestations of hyperemotivitis, anxiety and disorders due to hyperexcitability.
FR1487M (en) New drug in particular for the treatment of disorders due to hyperlipemia.
FR2467M (en) New drug in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR3009M (en) New drug in particular for the treatment of protein anabolism and disorders due to hyperfolliculinia.
FR1284M (en) Medicinal product for the treatment of primary hypogonadotrophic amenorrhea and related conditions.